Replies to post #156289 on Anavex Life Sciences Corp (AVXL)

[TTTav66]

Also worthwhile to keep in mind this exchange from the Q2 earnings call:

Robert Michael LeBoyer, Roth Capital Partners, LLC, Research Division - MD & Senior Research Analyst [6]

--------------------------------------------------------------------------------

And just on the financial side, are you expecting any increases in the quarterly spending this year? Is it something that would be sequential and gradual or any inflection points or any guidance for expense levels?

--------------------------------------------------------------------------------

Christopher U. Missling, Anavex Life Sciences Corp. - Chairman, President, CEO & Secretary [7]

--------------------------------------------------------------------------------

We actually will expect not a real increase or not a significant one for 2 factors. First of all, we expect a reimbursement from the government in Australia for the prior advanced or repayment of contribution of grants. And the second part is that, our payments of the clinical trials is already basically in process because the trial is not paid over the period of when [they] start actually -- the trial actually initiates, but it's evened out over the entire period of a study, and the study also includes preparation and for that reason, the budget in the forthcoming quarters will not be much different than the previous quarters.

https://finance.yahoo.com/news/edited-transcript-avxl-earnings-conference-100143339.html (I made a couple minor corrections to obvious errors in the transcript)